losartan has been researched along with Degenerative Diseases, Central Nervous System in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| " Growing evidence reveal that Angiotensin II (Ang II) contributes to the pathogenesis of Alzheimer disease (AD)." | 3.91 | Angiotensin II triggers autophagy and apoptosis in PC12 cell line: An in vitro Alzheimer's disease model. ( Lin, X; Lu, J; Shi, J; Tian, M; Wu, L; Zhang, Y, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, M | 1 |
| Lin, X | 1 |
| Wu, L | 1 |
| Lu, J | 1 |
| Zhang, Y | 1 |
| Shi, J | 1 |
1 other study available for losartan and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Angiotensin II triggers autophagy and apoptosis in PC12 cell line: An in vitro Alzheimer's disease model.
Topics: Alzheimer Disease; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Auto | 2019 |